Literature DB >> 22056346

I-131-MIBG therapies.

Stefan Vöö1, Jan Bucerius, Felix M Mottaghy.   

Abstract

Metaiodobenzylguanidine (MIBG) is a tracer that selectively targets neuroendocrine cells. On this basis, radiolabeled iodinated-MIBG (I-131-MIBG) has been introduced as a molecular nuclear therapy in the management of neuroendocrine tumors, including neuroblastoma, pheochromocytoma, paraganglioma, neuroendocrine carcinomas, and other rare neuroendocrine tumors. Extensive work has been addressed to develop I-131-MIBG therapy: doses, therapeutic schemes, and efficiency. In this paper, we present an overview on I-131-MIBG therapy, with main focus on different aspects how to perform this treatment.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22056346     DOI： 10.1016/j.ymeth.2011.10.006

Source DB:  PubMed          Journal:  Methods        ISSN： 1046-2023            Impact factor:   3.608


  7 in total

Review 1.  [Radionuclide therapy of endocrine-related cancer].

Authors:  C Kratochwil; F L Giesel
Journal:  Radiologe       Date:  2014-10       Impact factor: 0.635

Review 2.  Molecular Imaging and Therapy for Neuroendocrine Tumors.

Authors:  Hemant Desai; Salvador Borges-Neto; Terence Z Wong
Journal:  Curr Treat Options Oncol       Date:  2019-08-29

3.  Transcript Analysis for Internal Biodosimetry Using Peripheral Blood from Neuroblastoma Patients Treated with (131)I-mIBG, a Targeted Radionuclide.

Authors:  David A Edmondson; Erin E Karski; Ayano Kohlgruber; Harsha Koneru; Katherine K Matthay; Shelly Allen; Christine L Hartmann; Leif E Peterson; Steven G DuBois; Matthew A Coleman
Journal:  Radiat Res       Date:  2016-08-24       Impact factor: 2.841

Review 4.  Pheochromocytoma: implications in tumorigenesis and the actual management.

Authors:  U Shah; A Giubellino; K Pacak
Journal:  Minerva Endocrinol       Date:  2012-06       Impact factor: 2.184

Review 5.  Current Consensus on I-131 MIBG Therapy.

Authors:  Daiki Kayano; Seigo Kinuya
Journal:  Nucl Med Mol Imaging       Date:  2018-05-03

6.  Calibration of Traceable Solid Mock (131)I Phantoms Used in an International SPECT Image Quantification Comparison.

Authors:  B E Zimmerman; L Pibida; L E King; D E Bergeron; J T Cessna; M M Mille
Journal:  J Res Natl Inst Stand Technol       Date:  2013-08-15

Review 7.  Radionuclides for Targeted Therapy: Physical Properties.

Authors:  Caroline Stokke; Monika Kvassheim; Johan Blakkisrud
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.